Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE launches public-run government authority
H.H. Sheikh Hamdan congratulates Emirati 'leaders of tomorrow' at special ceremony
Dubai's Al Satwa Roundabout turns into signalised intersection
Dubai launches digital platform to strengthen AI literacy for families
Dubai Police add 920-horsepower Lamborghini to supercar fleet
